40,288 Exelon Corporation $EXC Shares Sold by Candriam S.C.A.

Exelon logo with Utilities background
Image from MarketBeat Media, LLC.

Key Points

  • Candriam S.C.A. trimmed its Exelon stake by 3.2% in the third quarter, selling 40,288 shares; it retained 1,212,479 shares valued at about $49.2 million. Institutional investors own 80.92% of the company’s stock.
  • Exelon reported quarterly EPS of $0.87, beating the $0.79 consensus, while revenue rose 9.2% year over year to $7.32 billion. The company also declared a quarterly dividend of $0.42 per share, equivalent to a 3.7% annualized yield.
  • Analyst sentiment is mostly neutral: five analysts rate Exelon a Buy, fourteen a Hold, and one a Sell, for a consensus Hold rating and a $48.33 price target.
  • Interested in Exelon? Here are five stocks we like better.

Candriam S.C.A. decreased its holdings in shares of Exelon Corporation (NASDAQ:EXC - Free Report) by 3.2% during the third quarter, according to its most recent filing with the SEC. The firm owned 1,212,479 shares of the company's stock after selling 40,288 shares during the period. Candriam S.C.A. owned 0.12% of Exelon worth $49,163,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. BlackRock Inc. acquired a new position in Exelon in the second quarter valued at approximately $5,583,709,000. Lazard Asset Management LLC raised its holdings in Exelon by 6.4% in the 1st quarter. Lazard Asset Management LLC now owns 24,620,304 shares of the company's stock worth $1,206,887,000 after purchasing an additional 1,490,251 shares during the period. GQG Partners LLC acquired a new position in Exelon in the 2nd quarter worth about $922,917,000. Legal & General Group Plc purchased a new position in Exelon during the second quarter worth approximately $602,760,000. Finally, Bank of New York Mellon Corp purchased a new position in Exelon during the second quarter worth approximately $580,842,000. 80.92% of the stock is owned by institutional investors.

Exelon Stock Performance

Shares of Exelon stock opened at $45.62 on Friday. The firm's fifty day simple moving average is $43.04 and its 200-day simple moving average is $45.62. Exelon Corporation has a 12 month low of $39.73 and a 12 month high of $50.65. The company has a debt-to-equity ratio of 1.70, a current ratio of 1.03 and a quick ratio of 0.93. The stock has a market capitalization of $47.21 billion, a price-to-earnings ratio of 17.75, a PEG ratio of 2.49 and a beta of 0.24.

Exelon (NASDAQ:EXC - Get Free Report) last announced its quarterly earnings data on Friday, October 30th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.79 by $0.08. Exelon had a net margin of 10.17% and a return on equity of 9.75%. The firm had revenue of $7.32 billion during the quarter, compared to analysts' expectations of $6.76 billion. During the same quarter last year, the business earned $0.86 earnings per share. The business's revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, equities analysts forecast that Exelon Corporation will post 2.87 earnings per share for the current year.

Exelon Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Friday, December 4th will be issued a $0.42 dividend. The ex-dividend date of this dividend is Friday, December 4th. This represents a $1.68 annualized dividend and a yield of 3.7%. Exelon's dividend payout ratio is 65.37%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on EXC. Argus cut their price objective on Exelon from $52.00 to $49.00 and set a "buy" rating for the company in a research report on Tuesday, September 22nd. Barclays reduced their target price on Exelon from $49.00 to $44.00 and set an "equal weight" rating for the company in a research note on Monday, October 19th. Morgan Stanley decreased their target price on Exelon from $50.00 to $49.00 and set an "equal weight" rating on the stock in a research report on Wednesday, October 21st. The Goldman Sachs Group dropped their price target on shares of Exelon from $45.00 to $44.00 in a research note on Thursday, October 15th. Finally, Weiss Ratings reissued a "buy (b-)" rating on shares of Exelon in a report on Tuesday, October 6th. Five equities research analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Exelon has a consensus rating of "Hold" and a consensus target price of $48.33.

Check Out Our Latest Stock Report on EXC

Exelon Company Profile

(Free Report)

Exelon is a regulated energy delivery company that operates electric and natural gas utilities. Its businesses deliver energy to homes and businesses, maintain utility infrastructure, and provide related customer services.

The company serves customers in Illinois, Pennsylvania, Maryland, Delaware, New Jersey, and the District of Columbia through utilities including ComEd, PECO, BGE, Pepco, Delmarva Power, and Atlantic City Electric. Exelon was formed in 2000 through the merger of PECO Energy and Unicom, then the parent of Commonwealth Edison.

Exelon separated its competitive power generation business, now known as Constellation Energy, in 2022.

Further Reading

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines